Volume 26 | Issue 10
ISSN (Print): 2053-0889
Most of the studies described were performed in healthy research animals. Thus far, only one clinical study performed in dogs has been published. It remains unclear whether vatinoxan should be used in homozygous dogs to check for abnormalities in the genes coding for the efflux transporter P-glycoprotein. Future work is needed to determine whether vatinoxan can be used in animals affected with this condition and those animals with other systemic abnormalities..
